Circulating cell-free miRNAs as biomarker for triple-negative breast cancer

BACKGROUND: Triple-negative breast cancer (TNBC) accounts for 15–20% of all breast cancer in women globally. This subtype often has early and high recurrence rates resulting in poor survival, partially due to lack of targeted therapies. Therefore, there is an urgent need to identify TNBC-specific bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, V Y, Siu, J M, Cheuk, I, Ng, E K O, Kwong, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647231/
https://www.ncbi.nlm.nih.gov/pubmed/25906045
http://dx.doi.org/10.1038/bjc.2015.143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647231/
https://www.ncbi.nlm.nih.gov/pubmed/25906045
http://dx.doi.org/10.1038/bjc.2015.143

Ejemplares similares